Latest filing published 18 Nov 2024 for HCA Healthcare, Inc., €499k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Kathleen M. Whalen on record concern HCA Healthcare, Inc., in the capacity of senior executive. Over a trading history stretching from 22 July 2021 to 14 November 2024, the count stands at 15 filings.
On the market, this insider has only sold: 7 sales, €4.1M in total. The rest of the record consists of 1 share grant and 4 option exercises. So far in 2024, the count stands at no purchases and 3 sales.
The newest entry dates from 18 November 2024: an open-market sale of €499k, in HCA Healthcare, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations